CEBPB and Miyoshi myopathy: High levels of IL-18 in the MM bone marrow microenvironment increase the immunosuppressive capacity of MDSCs via C/EBPβ, and elevated IL-18 levels in the bone marrow of MM patients are consequently associated with poor patient prognosis [99].